# The $632,000 Cancer Drug Being Tested Before Cancer Appears

- slug: the-632000-cancer-drug-being-tested-before-cancer-appears
- date: 2026-04-20
- category: Biotech & Life Sciences

Twenty patients who don't yet have active cancer received Carvykti, a $632,000 one-time CAR-T therapy. All 20 showed no detectable disease after 15 months. Medicare covers CAR-T for cancers — but not for people who aren't sick yet, and the price doesn't fit the payment model.

---